For Kalra, menopause marks “a movement from a life organised around duty and being needed, to a life organised around dignity ...
As of Wednesday, December 31, Corcept Therapeutics Incorporated’s CORT share price has dipped by 47.02%, which has investors ...
A UC San Diego lab recently announced a pair of scientific breakthroughs for Pitt-Hopkins and Rett syndromes that are slated ...
Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — Avinasi Labs, an AI-native ...
Inside a single-story brick building in Sorrento Mesa is a small lab sprinkled with beakers, test tubes and incubators that is worth billions of dollars. This is where Cidara, a small San Diego ...
As of Wednesday, December 31, Axsome Therapeutics, Inc.’s AXSM share price has surged by 17.93%, which has investors ...
Negative symptoms of schizophrenia affect motivation, emotion, and daily life. Learn the signs, why they’re often missed, and ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
TipRanks on MSN
Almirall advances LAD603 phase 2 alopecia trial, adding optionality to its dermatology pipeline
Almirall SA ($GB:0O9B) announced an update on their ongoing clinical study. Study Overview: Almirall S.A. is running a phase 2 trial called “A ...
Dupilumab, a fully human monoclonal antibody, inhibits the signaling of the interleukin 4 (IL-4) and IL-13 pathways.
Climb Bio Inc. (NASDAQ:CLYM) is one of the best biotech penny stocks to buy according to analysts. On December 18, H.C.
When a biotech company announces positive Phase 3 trial results or receives FDA approval, the market reaction is often immediate and substantial. This is not just speculation. These milestones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results